GO
Loading...

California

More

  • Dreamworks reports 2Q loss Tuesday, 29 Jul 2014 | 6:27 PM ET

    GLENDALE, Calif.— Dreamworks Animation SKG Inc. on Tuesday reported a second-quarter loss after posting a profit in the same period a year earlier. The Glendale, California- based company reported a loss of $15.4 million, or 18 cents per share, compared with a profit of $22.3 million, or 26 cents per share, in the same quarter a year earlier.

  • July 29- Amgen Inc on Tuesday said it would cut up to 15 percent of its work force and close plants in a series of moves aimed at reallocating resources as it prepares to introduce new medicines it hopes will drive future growth.

  • Business Highlights Tuesday, 29 Jul 2014 | 6:03 PM ET

    SAN FRANCISCO— Dustin Moskovitz has learned a lot about communication since he teamed up with his college roommate Mark Zuckerberg to create Facebook a decade ago.

  • July 29- Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of heart valves that are implanted using a less-invasive procedure than traditional open-heart surgery.

  • July 29- Amgen Inc on Tuesday said it would cut up to 15 percent of its global work force and close plants as part of a series of moves aimed at reallocating resources as it prepares for the eventual launch of medicines it hopes will drive future growth.

  • SHANGHAI/ HONG KONG, July 30- When inspectors visited Shanghai Husi Food Co Ltd earlier this summer, the production line at the plant now at the centre of an international food scandal appeared in good order, with fresh meat being handled by properly-attired workers and supervisors keeping a watchful eye over the process.

  • July 29- Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of heart valves that are implanted using a less-invasive procedure than traditional open-heart surgery.

  • Twitter 2Q results soar, stock flies high Tuesday, 29 Jul 2014 | 4:38 PM ET

    Stronger-than-expected financial results pushed Twitter's stock sharply higher on Tuesday after the short messaging service said its revenue more than doubled in the second quarter. Twitter also grew its user base more than expected, alleviating concerns, at least for now, that it doesn't hold appeal for a broad swath of people.

  • Nielsen's top prime-time programs for July 21-27 Tuesday, 29 Jul 2014 | 4:30 PM ET

    3. "NCIS," CBS, 8.7 million. 4. "60 Minutes," CBS, 7.66 million. 5. "The Big Bang Theory," CBS, 7.13 million.

  • CBS shifts schedule to boost ratings for 'Extant' Tuesday, 29 Jul 2014 | 4:29 PM ET

    NEW YORK— "Extant" is getting a kick-start from CBS to try to improve its ratings less than a month into its run. Starting Wednesday, CBS is moving the drama starring Halle Berry back an hour, to 10 p.m. EDT, so that it follows "Criminal Minds." That was enough to make Nielsen's top 10 for the week, and CBS says "Extant" picks up significant time-shifted viewership.

  • July 29- Panera Bread Co on Tuesday reported a 4 percent decline in quarterly profit as it works to speed up service at its popular bakery cafes. Net income fell to $49.2 million, or $1.82 per share, for the second quarter that ended on July 1. Panera earned $51.0 million, or $1.74 per share, in the year-ago quarter, when the company had more shares outstanding.

  • Report: Health premiums rose significantly in 2014 Tuesday, 29 Jul 2014 | 4:20 PM ET

    SACRAMENTO, Calif.— California's insurance commissioner released a report Tuesday showing the cost of health-care premiums increased significantly this year, as he pushes for more authority to regulate those costs.

  • OKCupid, Facebook not alone in studying consumers Tuesday, 29 Jul 2014 | 4:09 PM ET

    NEW YORK— Think you're in control? The New York- based Internet company's revelation follows news earlier this month that Facebook let researchers change news feeds to see how it would affect users' moods.

  • Biotech drugmaker Amgen laying off at least 2,400 Tuesday, 29 Jul 2014 | 4:04 PM ET

    Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations. Amgen also raised its forecasts for its 2014 profit and revenue, driving up its shares.

  • Lawmakers employ gimmicks to pay for highway funds Tuesday, 29 Jul 2014 | 3:41 PM ET

    WASHINGTON— The House and Senate have passed competing versions of legislation to prevent the federal trust funds providing highway and transit funds from running dry next month and to buy more time for Congress to draft a new highway bill.

  • Impax Labs shares slump after FDA inspection Tuesday, 29 Jul 2014 | 3:38 PM ET

    NEW YORK— Shares of Impax Labs sank Tuesday after an FDA inspection uncovered potential problems at a facility where the company will make its experimental Parkinson's disease drug Rytary. Impax has been unable to get marketing approval for Rytary because of problems stemming from FDA inspections.

  • SEATTLE, July 29- Microsoft Corp's hardware chief gave employees a sneak peek at a' selfie' phone featuring a 5 megapixel forward-facing camera at an internal meeting this week, a source at the company said on Tuesday.

  • SAN FRANCISCO, July 29- The U.S. judge overseeing a criminal drug prosecution against FedEx Corp said one of the core issues will be what FedEx executives knew about illegal online pharmacies whose packages it shipped. FedEx was indicted earlier this month on 15 criminal counts, including conspiracy to distribute controlled substances.

  • SEATTLE, July 29- Microsoft Corp's hardware chief gave employees a sneak peak at a' selfie' phone featuring a 5 megapixel forward-facing camera at an internal meeting this week, a source at the company said on Tuesday.

  • WASHINGTON, July 29- The Obama administration on Tuesday pushed for Congress to renew a 14- year-old trade program giving African countries duty-free access to U.S. markets, warning that allowing the program to expire would disrupt trade flows between the two regions.